D.E. Shaw & Co
TYRA icon

D.E. Shaw & Co’s Tyra Biosciences TYRA Stock Holding History

D.E. Shaw & Co’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,003
Closed -$752K – 4892
2024
Q3 		$752K Buy
+32,003
New +$672K ﹤0.01% 3466
2023
Q1 		– Sell
-33,005
Closed -$251K – 4875
2022
Q4 		$251K Sell
33,005
-1,881
-5% -$13.3K ﹤0.01% 4156
2022
Q3 		$307K Sell
34,886
-21,168
-38% -$194K ﹤0.01% 4286
2022
Q2 		$401K Sell
56,054
-27,384
-33% -$218K ﹤0.01% 4224
2022
Q1 		$893K Sell
83,438
-44,425
-35% -$527K ﹤0.01% 4007
2021
Q4 		$1.8M Buy
+127,863
New +$2.54M ﹤0.01% 3448

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co's TYRA Position: Q4 2024 in Review

D.E. Shaw & Co sold out of Tyra Biosciences (TYRA) in Q4 2024, closing a stake of 32,003 shares — an estimated $752K sold.

D.E. Shaw & Co first reported a position in TYRA in Q4 2021 and held it in 6 quarters. The position peaked at $1.8M in Q4 2021. 113 funds tracked by Wall St. Rank hold TYRA as of Q4 2024.

  • D.E. Shaw & Co reported no remaining Tyra Biosciences position as of Q4 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 32,003 Tyra Biosciences shares in Q4 2024, an estimated $752K.
  • D.E. Shaw & Co first reported a position in Tyra Biosciences in Q4 2021 and held it in 6 quarters.
  • D.E. Shaw & Co's Tyra Biosciences position peaked at $1.8M in Q4 2021.
  • 113 funds tracked by Wall St. Rank held Tyra Biosciences as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.